Fig. 7From: Identification of immune-related biomarkers associated with tumorigenesis and prognosis in cutaneous melanoma patientsCXCL9, 10, 13 and CCL4, 5 were significantly overexpressed in stage I and decreased in subsequent stages (P value < 0.001)Back to article page